Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.198
-0.026 (-11.70%)
Apr 29, 2026, 9:51 AM EDT - Market open
Calidi Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 5.6 | 9.59 | 1.95 | 0.37 | 2.14 | Upgrade
|
| Cash & Short-Term Investments | 5.6 | 9.59 | 1.95 | 0.37 | 2.14 | Upgrade
|
| Cash Growth | -41.61% | 392.10% | 423.93% | -82.59% | 408.81% | Upgrade
|
| Other Receivables | - | - | 1.36 | - | - | Upgrade
|
| Receivables | - | - | 1.36 | - | - | Upgrade
|
| Prepaid Expenses | 0.42 | 0.39 | 0.77 | 0.31 | 0.5 | Upgrade
|
| Restricted Cash | - | - | - | 0.1 | 0.1 | Upgrade
|
| Other Current Assets | 0.23 | 0.25 | 0.23 | - | - | Upgrade
|
| Total Current Assets | 6.26 | 10.23 | 4.3 | 0.79 | 2.74 | Upgrade
|
| Property, Plant & Equipment | 2.46 | 3.8 | 5.34 | 1.09 | 0.59 | Upgrade
|
| Other Long-Term Assets | 0.14 | 0.15 | 0.37 | 0.73 | 0.07 | Upgrade
|
| Total Assets | 8.86 | 14.18 | 10.02 | 2.6 | 3.39 | Upgrade
|
| Accounts Payable | 0.61 | 2.07 | 2.88 | 2.27 | 0.62 | Upgrade
|
| Accrued Expenses | 1.81 | 2.98 | 5.43 | 5.35 | 3.51 | Upgrade
|
| Short-Term Debt | - | 0.47 | 0.53 | 3.46 | 5 | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.7 | 0.28 | 1.96 | - | Upgrade
|
| Current Portion of Leases | 1.52 | 1.27 | 1.12 | 0.12 | 0.14 | Upgrade
|
| Other Current Liabilities | - | - | - | 29.83 | 16.69 | Upgrade
|
| Total Current Liabilities | 3.94 | 9.5 | 10.23 | 42.99 | 25.96 | Upgrade
|
| Long-Term Debt | 0.6 | 0.6 | 2.06 | - | - | Upgrade
|
| Long-Term Leases | 0.45 | 1.99 | 3.25 | 0.45 | 0.04 | Upgrade
|
| Other Long-Term Liabilities | 0.12 | 0.13 | 2.71 | - | - | Upgrade
|
| Total Liabilities | 5.1 | 12.21 | 18.25 | 43.44 | 26 | Upgrade
|
| Common Stock | 0 | - | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 145.39 | 123.28 | 91.38 | 19.93 | 13.32 | Upgrade
|
| Retained Earnings | -141.62 | -121.72 | -99.57 | -70.36 | -44.93 | Upgrade
|
| Comprehensive Income & Other | -0.01 | -0.03 | -0.05 | -0.01 | -0 | Upgrade
|
| Total Common Equity | 3.76 | 1.53 | -8.24 | -50.44 | -31.61 | Upgrade
|
| Minority Interest | - | 0.43 | - | - | - | Upgrade
|
| Shareholders' Equity | 3.76 | 1.97 | -8.24 | -40.84 | -22.61 | Upgrade
|
| Total Liabilities & Equity | 8.86 | 14.18 | 10.02 | 2.6 | 3.39 | Upgrade
|
| Total Debt | 2.56 | 7.04 | 7.24 | 5.99 | 5.18 | Upgrade
|
| Net Cash (Debt) | 3.04 | 2.56 | -5.29 | -5.62 | -3.04 | Upgrade
|
| Net Cash Growth | 18.83% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.71 | 3.83 | -37.63 | -79.24 | -18.50 | Upgrade
|
| Filing Date Shares Outstanding | 11.05 | 2.52 | 0.3 | 20.62 | 19.93 | Upgrade
|
| Total Common Shares Outstanding | 7.37 | 1.88 | 0.3 | 20.62 | 19.93 | Upgrade
|
| Working Capital | 2.32 | 0.73 | -5.93 | -42.2 | -23.22 | Upgrade
|
| Book Value Per Share | 0.51 | 0.82 | -27.82 | -2.45 | -1.59 | Upgrade
|
| Tangible Book Value | 3.76 | 1.53 | -8.24 | -50.44 | -31.61 | Upgrade
|
| Tangible Book Value Per Share | 0.51 | 0.82 | -27.82 | -2.45 | -1.59 | Upgrade
|
| Machinery | 1.8 | 1.64 | 1.66 | 1.1 | 0.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.